English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jan 27, 2026

Biotech firms emphasize flexible manufacturing strategies after J.P. Morgan Healthcare Conference
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

Lotte Biologics focuses on global quality expansion ahead of new campus opening
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

AbbVie and Genmab report Phase III lymphoma study results for bispecific antibody Epkinly
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

Novo Nordisk sees strong initial uptake for oral Wegovy amid rising competition
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

Galapagos CEO outlines strategy shift after winding down cell therapy operations
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

SpyGlass Pharma and AgomAb Therapeutics file for Nasdaq IPOs
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

Brain structure changes may explain reduced adaptability in aging adults
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

Biotech firms emphasize regulatory alignment amid ongoing uncertainty after recent FDA reversals

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes